Google TrendLAMINE YAMAL (5000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Managing Vasomotor Sympto" (30 stories)

Top Headline Story

Management of Vasomotor Symptoms in Women With Breast Cancer: From Pathophysiology to the Emerging Role of Neurokinin Receptor Antagonism
Lead StoryCureusgeneral
4d ago

Management of Vasomotor Symptoms in Women With Breast Cancer: From Pathophysiology to the Emerging Role of Neurokinin Receptor Antagonism

<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxPclZTR05jRmxmNmFxVUdsbXNQRzFSbHRzSzc2emdtV2ZLZGpDS2FCWXEwNnpTRlZwc0luRG1aWWpTbTdmQ1ZSbElVb1JQSWFTeWFSc2ZJSDc3dWFUdVpMNzNpRWZnZzN4cGVWRzFjWEZnVlJIUXdLZ3Z0VXdzRVB4UmVBR3pySzk4MEdLNU9yakFVZ2J1ZmlYTy1lQWRnNmhoeE42Ty1nRllzU3YySFdQOVE1VmsyS3gtcHM2eEVsRVNwLU5mRy00YjZpQ2pGNEtjX2hQUS1xVmNPRGY1dHhIZmtyQmhjVG1Iekk0SjhvRnVoME9BUER2cmEtaWFZT1Uyb1pGSmp3?oc=5" target="_blank">Management of Vasomotor Symptoms in Women With Breast Cancer: From Pathophysiology to the Emerging Role of Neurokinin Receptor Antagonism</a>  <font color="#6f6f6f">Cureus</font>

Real-time search volume
5000+30m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

500+30m ago

thélyson orélien

Acclaimed Author Denies Using A.I. but Admits Plagiarism

500+30m ago

adeyemi

Licensable picture: Galatasaray v Barcelona - UEFA Champions League

500+40m ago

abdulrahman alfozan

Saudi national OpenAI employee arrested after 'sophisticated recording device' planted in office

Search Results for "Managing Vasomotor Sympto"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Taking Control of Vasomotor Symptoms in Breast Cancer
Medscapegeneral

Taking Control of Vasomotor Symptoms in Breast Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxORi1nS3V6SkFHYjVrRzV5RnF4OThwUUdnUjVSbktRR0ZmdFF0a3l6N0lsLUIta2NlOEdYQVhrNnpYaFVlVWtYbjlQODRpU05sSkJYSENyWTJwcFFuUWNtaEdkT2k2TjFUcl9nM1FnN2kzc0xPdFlpMkxpOXFrWVhwcXJrMks5YzV6aEo3U3JpLTFxaWpndEJzRjRZdl91WW1fUTJuU3FJWlZ0SXFF?oc=5" target="_blank">Taking Control of Vasomotor Symptoms in Breast Cancer</a>  <font color="#6f6f6f">Medscape</font>

Hormone therapy, neurokinin antagonists, and the evolving menopause treatment landscape
Contemporary OB/GYNgeneral

Hormone therapy, neurokinin antagonists, and the evolving menopause treatment landscape

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOUV9IZWJpWWdfaHc2NVlQUlFqckhZdFFiTGZaZzFVNHB2dzNveFlFWW9BOUFqcTFsTWRaQXdFaGFKVkp4cUtuTEtRczlGWU9PUk4xdUdSdXEtdTRwczV5TXZzanpMWVE5bUV2RTdsbkR5aEh0dGpndVpoQkVUbjVQa011LTNidnZUQlJUbW1xX3dNTFRpUUtORW5NVG1IMXlNcXMzR0hXcDU4TDQ0Y2k5QW1OUnF3VjNJU2ZWaGhqU0U1dw?oc=5" target="_blank">Hormone therapy, neurokinin antagonists, and the evolving menopause treatment landscape</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Elinzanetant: Advancing Treatment for Vasomotor Symptoms
Pharmacy Timesgeneral

Elinzanetant: Advancing Treatment for Vasomotor Symptoms

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQRVdVSjBMamY5UldJb3E2OU9STnl2QndVMFV4Vl9tSndwSTJjRk9GYnBsejRFa29zcmZVeDBVRVpfdWVjSDQ5VlltYWdzLVg3a2lHWlFDdkFQTmRTODRDY2JuR1U3UlB3SlRabG1MU1dFOUZHR1NPRlJDME9HUG04YVp3Z1Bwc2dJMThrN0RvbjFZT3Qx?oc=5" target="_blank">Elinzanetant: Advancing Treatment for Vasomotor Symptoms</a>  <font color="#6f6f6f">Pharmacy Times</font>

Menopause Management: When Hormone Therapy Is Appropriate
American Academy Of Family Physicians | AAFPgeneral

Menopause Management: When Hormone Therapy Is Appropriate

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9OdHhmVktuSWU0RGdVV2s5b2NmQ2Z4UzVDdFgzQkV2Y0ozb0ZtOFBLZkFOLXpaX3BzOHI1MU5aWmNtaF8yQWcwdjVvZmFTZFBCb1ZHNVRVVGxVMHExalcyTXRVeXpkdFIwdEc1VE80ak9mMTZ1?oc=5" target="_blank">Menopause Management: When Hormone Therapy Is Appropriate</a>  <font color="#6f6f6f">American Academy Of Family Physicians | AAFP</font>

Unmet Needs in Managing Vasomotor Symptoms in Menopause
Patient Care Onlineworld

Unmet Needs in Managing Vasomotor Symptoms in Menopause

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPTGVnOS13S2hkS0V6V3dlNmw2T3RUOHJNRnBERDVNZmN5SE1jWFNkSUVUaVJZOFp1Snk0ci05OUVuWDlHRHl2N1ljVmttdnI0VU9XWEpHam9adUljU2dsTTZlZWxQWFhFSzRuNkpzdjdOUExGakNNRGJWYjNBc2hqT0ZGU0ZvZGJnb3IzejFhMGpxNjFwcWU3SlRn?oc=5" target="_blank">Unmet Needs in Managing Vasomotor Symptoms in Menopause</a>  <font color="#6f6f6f">Patient Care Online</font>

Special Report: Managing vasomotor symptoms in menopause
Contemporary OB/GYNgeneral

Special Report: Managing vasomotor symptoms in menopause

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPVGhndGxyWXo3VWJsRldSdjQ5RnBMaTBiVW11cEJ6ZVRsOGJhQ3RoNzJjZ0Ruam5nSDZoeFg4ci1UeWhTN3lRTzgtOG5JMlBvRmJiNnJteDRhWEZUNEtFUUNjaGwyRDBMSjljR0g2V0poU19Ta0M5eGVYY3RWUVR4WXRZWW1pWUlieWdpSFhrS0hoRjZqWG1sa2RfaFN0b0c5U3ZEeG9ZSQ?oc=5" target="_blank">Special Report: Managing vasomotor symptoms in menopause</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause
Patient Care Onlinegeneral

Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQZzJ2NmZHTUtDNmdSUWpMNWhkb1VBeUx6eEVROXZyNHJkOEU4ak4yUzl5SVF5eGhxb29Ud3NlaWZRVU1JbHhoZlEtY09QdGJmbXZxV240MUZlalNROEZXa19qVGp2N05iYjJUQ2dlMkJ3OGdscWtySGtRUlp4WWtWRFUtU0pZN0ZBSmlXa0x6UUx6bUJUeDdPMTA1Uk9uWGdKWWZPVEVNLTNzcDIxcEhsNmlvV1BjNVRkZWlTZXl4aEZTUXc1NllnTkd0MA?oc=5" target="_blank">Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause</a>  <font color="#6f6f6f">Patient Care Online</font>

Estetrol Improves Vasomotor Symptoms With No BP Effects
Medscapegeneral

Estetrol Improves Vasomotor Symptoms With No BP Effects

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPRVZkM0haS3VZamhMMHl0QkEyclZrMlpuRU9wU2g1ckl4RTNCVG1VOTl3c2pJeVZMS1JERkNpMk5WUU5JNW5HN3E0eE9kejhBbS1qdkNCV2p5bXhsNDliRDR3OFhSUzdwZHNJTVRMWV9TS0ZsNUwzOTJsSm8xelJDM3RscENPUG8xdjVrV0hsMHZKXzBybzhaenNiNDFIc0czS1dDT0FWMjBudw?oc=5" target="_blank">Estetrol Improves Vasomotor Symptoms With No BP Effects</a>  <font color="#6f6f6f">Medscape</font>

Managing Vasomotor Symptoms: Understanding the Menopause Transition and Treatment Options
Pharmacy Timesworld

Managing Vasomotor Symptoms: Understanding the Menopause Transition and Treatment Options

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMlRVV0Nfa0xSb2p0NXpuSVFzQXg0M3hubllESDdmbGhrOUdVMmlSNGUxbEQ4RnZvRFJpODVXMTZzcVdXVXQxXzktdkZPR3FEWVZhcnFsMW9EdVB0WVZINFAwOWN0T1c2N183UWEyMkRoUU5VSm5jZnNBQnBkTTN0QWZoVGRMSzhnQXhKQ2xTa3JjYVBhdXpOVU9QVHc3SVVUSEFYanZyUjlCcUh2Qkc3blFfcjNUdksxTmozSGZHbk4?oc=5" target="_blank">Managing Vasomotor Symptoms: Understanding the Menopause Transition and Treatment Options</a>  <font color="#6f6f6f">Pharmacy Times</font>

Unmet Needs in Managing Vasomotor Symptoms in Menopause
Contemporary OB/GYNworld

Unmet Needs in Managing Vasomotor Symptoms in Menopause

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPU01vaHVtT2ZubF8zMEw2NVlhZ1RZSTRKLVM5TEZHTTBULTQtQVpHMDJoMGJSc09WcFc0TDgyMGNPY0Y2MmhVRzRYeGxNekFmWmZwQnhpRHBUcUlRajFZdGhGaC1tVGlWTV9FSEUwSE1hRklLRHdhTnRxRmtQa2MycmlpTkJabjlpUnVvWGxQY1Z1amNYcUQ5TGdn?oc=5" target="_blank">Unmet Needs in Managing Vasomotor Symptoms in Menopause</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Managing Vasomotor Symptoms With NK3 Receptor Antagonism
Patient Care Onlinegeneral

Managing Vasomotor Symptoms With NK3 Receptor Antagonism

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPa0ZFN2hzQmRXVlh1cnIwY19yQkZDeW5KSWVoVF90MUpROS1pRWRBbzNmS3dILW9zZzlzNFlVYUlEcU03cHdVLWRwR3Z0aXVDVDZhbFI0WXplWkJBODhfV3dBakY2YmthLWFmSHBTUE50VU9HQlY0OGpOQlRPZEJvaHp2UVFLbUx2TUFSRDhOQkZZVlZScThpYWJXRQ?oc=5" target="_blank">Managing Vasomotor Symptoms With NK3 Receptor Antagonism</a>  <font color="#6f6f6f">Patient Care Online</font>

Managing VMS in Breast Cancer Survivors: Treatment Considerations and Guidelines
Contemporary OB/GYNgeneral

Managing VMS in Breast Cancer Survivors: Treatment Considerations and Guidelines

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPaEtmcDVkUmUtWE1wZ0tLbzlydTZzeV94TVExcUMycDlRTklvYmNPdkdUOWQtMWVxa08td01jU1M4cFBQQ0pNajNRNl9iRjdyQ0dDYXdOdU12SDkta3BQVUpRNXJtb2ktcVZRdmhrS3F2c3dyVTVXdWhfZ0FBdG94cmg4SS1QN0gxNFpEYmNQT3ItMFgxYUVGN2xYNXQzczgyWFRWaEdxMXdtNHlzTWVxRGJFbUl1c3JJYmc?oc=5" target="_blank">Managing VMS in Breast Cancer Survivors: Treatment Considerations and Guidelines</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Unmet Needs in Vasomotor Symptoms in African American Women and the Road Ahead
Contemporary OB/GYNworld

Unmet Needs in Vasomotor Symptoms in African American Women and the Road Ahead

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxON0M2QWZ1bk83Zkk5OUpBbm1VcVQ3NkZPckI3SThRa3p0V3hQazdtVjdQWXR3QVhhbmg5eEx4U3BYeWJRdVgwcWJBVlhBYV80ZXRxd0lCNnU0c0gtTDNXNV8wdXFIRUxHYUphNFB1ZnQyRTdsekxJRWxvd3RJSDVBNTFuQ01oNllNM2hncUZ0UXREV3UwRmpFNWZEcWdVdWVJLXNOdlh0NUdLNVRHUmxsckp4SVRDczVK?oc=5" target="_blank">Unmet Needs in Vasomotor Symptoms in African American Women and the Road Ahead</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Managing Vasomotor Symptoms with NK3 Receptor Antagonism
Contemporary OB/GYNgeneral

Managing Vasomotor Symptoms with NK3 Receptor Antagonism

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPbi1PTktzOHJuSXZ2ckZCckFBSjRnNnRRYlVackxnWTVrcVBmUUREMXdYVXRQdXJXN0JKUmVRTTB0c3hkMWNiUTl3bkh4Z0diOFFaaGpWdkxSN0F6U0lJUXg0YWNuVGxsMzZYd1RuMVBsYzkyelh5ZGhhbW41cUhFQnVlWnRkdUZNMU9hc0lBdDllNkw2OVpUMG1lRQ?oc=5" target="_blank">Managing Vasomotor Symptoms with NK3 Receptor Antagonism</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

New nonhormonal therapies transform hot flash treatment in menopause
Contemporary OB/GYNgeneral

New nonhormonal therapies transform hot flash treatment in menopause

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUEU0REd0WVVvVmI3djV6TGNNa0NhWWwyeUdKb0NSTS01ejhiM3htaUxuS2VLQm5mUGYxUnN0azdWZ01iN1JsV2tfMVRtbGQyd0M1dlQycW1DNDhMQTBjcUt6LTBFejMwUVV5ZUkzTFRvSFhaSVBHcm1fTnVzbVpVcHRWVkJhcUFCN3QyMVlzX1JSR2h2OXNXRExUUllNRTRHeDAyWmFVaGpDb3c?oc=5" target="_blank">New nonhormonal therapies transform hot flash treatment in menopause</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options
Contemporary OB/GYNgeneral

Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbkdsNER4NE91MXcyMjV3OU1icHhSZExwSFFYTmx3UmxSRXUyZnQxWjRyRDUwNUFZcFdENXFBbERHd1dfWnV2cUhWVWxjeDBwVXFWRzVLUHpNaHpac1FOcDVGQXdUNkM3Yjk5RmtTNVRiR21fWklyV3o2cFZpRFVqckVRZ21keUNaRm5GQWNFXzdRam05SEhRREs5SEtNdjd6Y0ltbzFGMWZya24tZFRWZk42Uy1aMWY2a0pKNWZHTVdBM1A2LUNIZQ?oc=5" target="_blank">Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women With Breast Cancer Receiving Endocrine Therapy
Patient Care Onlinegeneral

Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women With Breast Cancer Receiving Endocrine Therapy

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxPQ1BKX1Zsc1hLVDB3d25VTTEzbjN5UGlCTEFTVFppUmlBMG5ZMjZZMXNiRl9GT3hjQ3lLa0lUSmxnblFYY1Mzc21NYm9mNTh1OEhtWXNYV1g4XzhMa09WWllFT283OWtiX3BTWW0teTVjXy1xWHBXYlFBd3FEeE42a3FDVkJIU0tZRXdnX3N6bFRvcnVNRTNJY0FjZEVzbS1GRTlFTV9SVjRXZ0VmeFJqMXdqaUxEWTFzY21yRkY0Z0R1V2lDYzc0OWtndTJJLU9XVGVHZXp2WEZOenNKd1FEdHpZSlQ3clk?oc=5" target="_blank">Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women With Breast Cancer Receiving Endocrine Therapy</a>  <font color="#6f6f6f">Patient Care Online</font>

Special Report: Future research outlook
Contemporary OB/GYNgeneral

Special Report: Future research outlook

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPb2p6MDZrMk5heVk4aDhCMXNMeUhONHdqNDhqdHlGVnh0dEtnTG9SZjcwa0hFcnJEMWNYNGptdEdvdHBOVDdzbHFIRmNqd3I5Nzg0ak5jSGtrU3BUMENsUWFsUjRXQk10U2dIYUU2dWRBaFItUkdfX2tXVFlpUkEySXhndw?oc=5" target="_blank">Special Report: Future research outlook</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape
Contemporary OB/GYNgeneral

Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOWklTbFh6NHhRSmVXNTNOMEp1djFYWnF0eHRoaHU2anJlcnZueUhQZkV3Wm1CRHdjdzNXd3FFY1hKNzBKZms5YkZuMUtWbmk0TTVZMktrMWx3RkdnQ3RUSHdLS1RmQ09uV1Y3bUNpOVBUVWN4eGZ3dEtMREVYSE1STFJ5ajJLVzhQVFBzRy1XYWw3Y2k5ODZiNS1GM3hVVWRQTjR6ZnlSZlZYc2sxdUpkQTR1WHkxanNlWVB0bDZmUTFOLWVpNTVvRkhnbw?oc=5" target="_blank">Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Impact of Vasomotor Symptoms on Patient Quality of Life
Patient Care Onlinegeneral

Impact of Vasomotor Symptoms on Patient Quality of Life

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQTmlzd1FMaHNZQWJ3SFhhazQ4dkpWcGNhYjk1VWRVY3pWYy1BbEgtcUx1bG8ybWdnd3JjaFJxS2Q1d1pLbmUxR2hjMEpGTTdOQ245c0l5MjZjYlhQUUY0Mk9sNTl3X3gxOW9GLVNMZjBMTFhxdkFJQlZwQ2dTVnB0RmN6UkxKZ1JLVFNTUzZkTW9RdWZYMWdNRWtR?oc=5" target="_blank">Impact of Vasomotor Symptoms on Patient Quality of Life</a>  <font color="#6f6f6f">Patient Care Online</font>

Special Report: Positioning emerging treatments relative to established options
Contemporary OB/GYNgeneral

Special Report: Positioning emerging treatments relative to established options

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVVhFNnVGNThzSmtVaTN1dFBTclhyR0hHVU5kVFBIVjVOTG5SUFI4SnZidE1uaUZNTmxReF9scDl2V3dTN29hOWVxS1c5dWZiRTVxUWp3bm90eGl2NWlkS0NzY3hCTU00THZNYXNka2o4S3JiTFRsX21pYjRLRVRyZF92TGFXWUVOd3pLSDdlVUI2YmJialZSSkdmZHVwanJVTmlpYlNieTAyZHFYU3BsRmk5UGN2WkhJ?oc=5" target="_blank">Special Report: Positioning emerging treatments relative to established options</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Special Report: How comorbidities and contraindications to hormone therapy influence treatment pathways
Contemporary OB/GYNtech

Special Report: How comorbidities and contraindications to hormone therapy influence treatment pathways

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxQTE0wT3Z3OF8wNEx3QnZ1Q2xKQVUxTGgwTFZJeWl4d3VwNGtmbnFCOWxTZWpNbXVKdEdab1E1eVEtT21WTTluNUhhY2E4UVZHSmN2bExqQWNfWWZTUmoyMGlfc242ckwzQlpyN2YtZjBfZDFwaW9KZEliaHBLeEx5N1hjQjJtUGtCUGpkNnNfeDJnanJtQ3duekx5N2tqTFJxcm85YnhHWWNxTG1hLVV5VDNyOFVDbGRnSDNuaGZTZ1IxZkREQ2lwRUhHa1pYRC04cDRZbm9fN1c?oc=5" target="_blank">Special Report: How comorbidities and contraindications to hormone therapy influence treatment pathways</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments
Patient Care Onlinegeneral

Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPQ3hLVkZSTUFLNTJGX000MkJmblFkQmxRZW9zVTVPQWdsY0pqNnNPOEtKQzdsNmpWbFRjTGtJQ1Y0OU5OdHhEU2lXdGdhejA0OHpRWjRVckFlQ09PUDVnSFVRcjlTcDk2YkQzU2dsdzQ0WFRPTThZNmNmOGI1SkdKMHJLbGxnZThGUGo3SDZLX0RQXzdYV0NDYlBZLTdUeGoyUU1EWngtWW1vRGdLRGNGS0JMbDA?oc=5" target="_blank">Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments</a>  <font color="#6f6f6f">Patient Care Online</font>

Special Report: Identifying gaps in care
Contemporary OB/GYNgeneral

Special Report: Identifying gaps in care

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPTy1MWkJHYkdIWkMzZmZmUW9JcnNkTTRhNkJ3TGVzUVpLaGduT1dxLUhaQ0NMM2U3WW5jc2hMajZIb0tYOWtzYk9OSEdsa20tRWFTYmdvZFNlSUZuVElyUFp5dkVYVDZURU1ld1pmVW1UM1lyVUY3NGxSd2xreE13S21OYmE?oc=5" target="_blank">Special Report: Identifying gaps in care</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

An update on the use of non-hormonal therapies for vasomotor symptoms of menopause
Royal Australian College of General Practitioners (RACGP)general

An update on the use of non-hormonal therapies for vasomotor symptoms of menopause

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNeGpXNlVnZUIxYURnSl9PeVp5LThFb09qY1FnUDJkVEZpNklWMnM4ZWZGNG9scWZaUFJ0WnpwZThXbWh0bmR6MlpQU0ZIRkZRaWRXaGtnUDlPU2dkdWhjRDh2LUlTNS1Rd2VoV0NydDJfb2RST3lrNnNHVlJKazRrWVc2SWJRT3FhdWZsdHBYYXNGZGphc2NB?oc=5" target="_blank">An update on the use of non-hormonal therapies for vasomotor symptoms of menopause</a>  <font color="#6f6f6f">Royal Australian College of General Practitioners (RACGP)</font>

Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep
Contemporary OB/GYNworld

Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNT0RkdW1nOHBmODZTOFhmd2NCSlFDaEVIWmtoRTZYbWFlY2ZmVndTc2c3VWlTUnh1NnBHdDFTOUl3Zk93SUxyWEVDOFlrTV80Slo5OFZHV21oYlBpSThnZVVCMHJpcU5ndnRVOXZWSFhhVUpTNWxuLWJPcFphaW8wbGwtRkJjY1hWN3pLQ3lkRWRfR25jRlczcWNUWW16TmxMM0NXdVRacmVrWG5Gc25saUtYQ2Rnc1JFa0RqTnBn?oc=5" target="_blank">Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Special Report: Latest updates, tailoring VMS treatment, and shared decision-making
Contemporary OB/GYNtech

Special Report: Latest updates, tailoring VMS treatment, and shared decision-making

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPVkxoTXZVbnNDOGZnY0R2UmZDRTFUWWNJeGt4cFNLenp0TjRaNUZLb0gxVHZjc2hjSUxQdE1ubUZkZ1NNakltVmo5Qm1DU0t1YmhOa1VTeWlfRUstZkt6QnVwRmt6X3htVU0tYVZ2eHhMOHZramVmdXNDQnlCVXhiV20xRlRTMmdPRlkweGp4V1U4dmFyYnh5T0tseWppTFlNM09CUzJTUzRqaG9FcGVGOFRkSGJNNUd2WVZJ?oc=5" target="_blank">Special Report: Latest updates, tailoring VMS treatment, and shared decision-making</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
Contemporary OB/GYNgeneral

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOLWtlNTVYTzh3d1VmUVNWNWFHODlQTHhzTEg2TVdYd2J5WXlVSXFUcjRDWm8teE4yb0FsdHZDREJaVmlyWjlrbmFTX1NUNUltV3Nhb0RoZnRJNFpEczFWcXFDT056SzlwMFUtTy1ndmYtdFJwNjBRMGRuOXc3UmltYUtOVFVhRG9neTJFZmQycUZGZXRGclV5djg4ZFMwWDgyLTdKWUw1QmpZUQ?oc=5" target="_blank">FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms</a>  <font color="#6f6f6f">Contemporary OB/GYN</font>

Review: Nonhormone Therapies for Menopausal Hot Flashes
Cleveland Clinicgeneral

Review: Nonhormone Therapies for Menopausal Hot Flashes

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQSWRWUnltTW1XWUtib05oNFNQN3pDODl0VWtBVkV5OEs4bmpTeHRDY3k5R21Fb2t4dS1KY00yZEFKcmp4VHV4TUxyX0x5ZDRLTUQ2UFdaU1ZNOEctNGphNm5uTFRUQ2kyVmpzV053TGM1SGlaWWtraWFKcDY1QzRsb0Q4ZzN6RkxoNlIyTFVrV1hnWmd5RXhMX1lIdnUySms?oc=5" target="_blank">Review: Nonhormone Therapies for Menopausal Hot Flashes</a>  <font color="#6f6f6f">Cleveland Clinic</font>

"Managing Vasomotor Sympto" — Live Google News Trends & Headlines